ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1967

Developing an Algorithm to Quantify Dermatomyositis-Associated Calcinosis Using Infrared Imaging

Saahil Sachdeva1, Briana Cervantes2, Lisa Rider3 and Adam Schiffenbauer4, 1NIEHS/NIBIB/NIH, Danville, CA, 2Department of Emergency Medicine, Norfolk, VA, 3National Institute of Environmental Health Sciences/National Institutes of Health, Environmental Autoimmunity Group, Bethesda, MD, 4National Institute of Health/National Institute of Dental and Craniofacial Research, Bethesda, MD

Meeting: ACR Convergence 2025

Keywords: autoimmune diseases, calcinosis, dermatomyositis, Imaging

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1936–1971) Imaging of Rheumatic Diseases Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Dermatomyositis (DM) is a rare autoimmune disease characterized by chronic muscle and skin inflammation. One potential complication of DM is calcinosis, the heterotopic calcification of soft tissue. The differences in depth and densities of these calcifications make early detection difficult by physical exam.Infrared imaging (IR) is a light-based modality that measures an object’s surface temperature. It has been used for other medical applications; however, IR imaging has not previously been employed for assessing DM-associated calcinosis. We proposed an IR algorithm to detect calcinosis in patients with juvenile and adult DM (J/DM) by measuring the value and variability of skin surface temperature. We believe its use will provide clinicians with a supplementary non-ionizing, inexpensive, and easy-to-use imaging modality to quantify DM-associated calcinosis at an early onset.

Methods: Study subjects were recruited from a myositis natural history study conducted at the National Institutes of Health in Bethesda, MD, and enrolled from August 2020 to July 2022. Inclusion criteria for the present study were probable or definite J/DM by Bohan and Peter criteria. Each patient also had suspicion of calcinosis, either self-reported or by documented assessment from a medical professional.Patient scans were conducted by an IR camera (ImageIR® 8300, InfraTec, Germany) at the NIH Clinical Center in Bethesda, MD. All scans were done in a temperature-controlled and humidity-monitored room (18-22 °C, 50-60 % humidity). Target scan locations were selected beforehand based on common calcinosis areas in J/DM, including the abdomen, back, arms, and legs. All images were taken as close to perpendicular to the patient as possible.

Results: Two hundred fifty-seven IR images from 3 DM and 12 JDM patients (age 9-60) were obtained from 6 body regions consisting of the right/left upper/lower extremities, abdomen, and back. For the population, the mean and range for CDASI activity, damage, and total calcinosis were (10, 2-41; 13, 2-25; 6, 2-11) respectively.The percent calcinosis area (PCA) was calculated as the pixels determined to contain calcinosis by the algorithm divided by the pixels determined to contain body area, multiplied by 100 to express the result as a percent. When PCA exceeded 15% to account for edge effect, the region was defined as positive for calcinosis. The calcinosis frequency of each region was calculated as the number of positive images of the region by its total number of images. The areas most and least frequently identified as positive for calcinosis by IR imaging were the upper right extremities and back, respectively.The IR algorithm’s suspected calcinosis areas ranged from 0.2% to 31.7%, with averages of each region ranging from 6.4 – 12.7% PCA (Table). Left and right extremities were within 0.6% of each other’s averages.Example IR image comparisons with traditional photography, physician exam, and CT are provided in Figure 1 and 2 from patients with calcinosis.

Conclusion: IR detected calcinosis in all body regions examined and demonstrated relative symmetry between left and right extremities. Further evaluation against other standards is required to validate the utility of IR in detecting calcinosis.

Supporting image 1

Supporting image 2Patient 1 had calcinosis in their left lower extremity distal to the knee. Image A is the IR image of this area and image B is the traditional photo of the same area. Image C is the physician drawing of the calcinosis from physical exam. Image D is the CT scan of the same area.

Patient 2 had calcinosis in their right upper extremity proximal to the elbow. Image E is the IR image of this area and Image F is the traditional photo of the same area. Image G is the physician drawing of the calcinosis from physical exam. Image H is the CT scan of the same area.


Disclosures: S. Sachdeva: None; B. Cervantes: None; L. Rider: None; A. Schiffenbauer: AstraZeneca, 11, Hope Pharmaceuticals, 5.

To cite this abstract in AMA style:

Sachdeva S, Cervantes B, Rider L, Schiffenbauer A. Developing an Algorithm to Quantify Dermatomyositis-Associated Calcinosis Using Infrared Imaging [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/developing-an-algorithm-to-quantify-dermatomyositis-associated-calcinosis-using-infrared-imaging/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/developing-an-algorithm-to-quantify-dermatomyositis-associated-calcinosis-using-infrared-imaging/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology